Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update on CKD-501 added to D150 Plus D745 10mg therapy in patients with type 2 diabetes; study completed.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating safety, tolerability, and renal effects of APX-115 in subjects with type 2 diabetes and nephropathy has …
-
CLINICAL_TRIALS withdrawal · 2021-08-24Clinical Trial Update: A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating a novel basal insulin titration approach (LY2963016) in type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD [Phase 3]
Phase 3 trial evaluating RVX000222 on time to major adverse cardiovascular events in high-risk type 2 diabetes with coronary artery disease …
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy [Phase 4]
Phase 4 trial comparing detemir to NPH insulin for gestational outcomes in pregnant individuals with type 2 diabetes mellitus; study complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial update for CPL-2009-0031 in uncontrolled type 2 diabetes mellitus has been completed.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients [Phase 2]
Phase 2 study evaluating safety and efficacy of CTP-499 in patients with type 2 diabetic nephropathy (type 2 diabetes mellitus with chronic …
-
FDA approval · 2021-08-13FDA Approved: LYUMJEV — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for LYUMJEV (insulin lispro-aabc) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Diabetes-Obstructive Sleep Apnea Treatment Trial [NA]
Clinical trial update for a study on diabetes and obstructive sleep apnea has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity [Phase 3]
Phase 3 trial update evaluating semaglutide for weight management in people with type 2 diabetes and overweight or obesity has completed wit…
-
FDA approval · 2021-08-11FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved an original application for a generic metformin hydrochloride product from Unichem Pharmaceuticals (USA), Inc., for the tre…
-
FDA approval · 2021-08-03FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for Glucotrol XL (glipizide) submitted by Roerig under NDA 020329.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Toujeo Versus NPH Self-titration Study [Phase 4]
Phase 4 trial comparing Toujeo to NPH in self-titration for type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: The Effects of SGLTi on Diabetic Cardiomyopathy [Phase 4]
Phase 4 trial update investigating the effects of SGLT inhibitors on diabetic cardiomyopathy in patients with type 2 diabetes and heart fail…
-
FDA approval · 2021-07-28FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Soliqua 100/33, a fixed-ratio combination of insulin glargine and lixisenatide, submitted by…
-
FDA approval · 2021-07-28FDA Approved: INSULIN GLARGINE — Original Application (Biocon Biologics Inc.)
FDA approved Biocon Biologics Inc.'s insulin glargine biosimilar under an Original Application, expanding access to insulin glargine therapy…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Study of Rivoglitazone in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial update for rivoglitazone in type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure [NA]
Clinical trial update documenting completed study on the effects of chronic ACE and DPP-4 inhibition on blood pressure in adults with type 2…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM [Phase 1, Phase 2]
Phase 1/2 trial update reporting multiple-dose tolerability and pharmacokinetics of IBI362 in Chinese patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin [Phase 1]
Phase 1 trial update on the interaction of Bexagliflozin with metformin, glimepiride and sitagliptin in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes . [Phase 2, Phase 3]
Clinical trial update evaluating vitamin D supplementation on inflammatory and endothelial factors in patients with Type 2 diabetes; phases …
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi [Phase 4]
Phase 4 trial update on de-intensifying insulin therapy using iGlarLixi in patients with Type 2 diabetes treated with insulin.
-
FDA approval · 2021-07-20FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for BASAGLAR KWIKPEN (insulin glargine) from Eli Lilly and Company. The submission status indicates …
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: To Bathe or Not to Bathe [NA]
The study on bathing versus non-bathing for individuals with Type 2 diabetes has completed, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone [Phase 2]
Phase IIb study evaluating BAY94-8862 for safety and efficacy in worsening chronic heart failure with left ventricular systolic dysfunction,…